ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES

ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES

Abstract Background Escherichia coli (E. coli) is a pathogen of great concern in immunosuppressed patients. While antimicrobial prophylactic therapy has become the standard, the emergence of resistant pathogens has some questioning its use. This study describes our experience with E.coli as a pa...

Full description

Bibliographic Details
Main Authors:	Daniel Olson, Abraham Tareq Yacoub, Gelenis Domingo, John Norman Greene
Format:	Article
Language:	English
Published:	PAGEPress Publications 2014-08-01
Series:	Mediterranean Journal of Hematology and Infectious Diseases
Subjects:	: Escherichia Coli Neutropenia Bone Marrow Transplant Hematological Malignancy
Online Access:	http://www.mjhid.org/index.php/mjhid/article/view/2049

Similar Items

Evaluation of Febrile Neutropenia in Hematologic Malignancy Patients
by: Müge ASLAN, et al.
Published: (2014-12-01)

Increasing Rates of Fluoroquinolone Resistance in Escherichia coli Blood and Urinary Isolates in Stem Cell Transplant and Hematologic Malignancy Populations
by: Christopher G. Hauck, et al.
Published: (2016-09-01)

EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA
by: Cumali Yalçın, et al.
Published: (2022-04-01)

Molecular characterization of extended-spectrum β-lactamase-producing <i>Escherichia coli</i> collected from patients with hematological malignancies during chemotherapy cycles
by: A. G. Korobova, et al.
Published: (2019-04-01)

Clinical characteristics and outcomes of <it>Mycobacterium tuberculosis </it>disease in adult patients with hematological malignancies
by: Chen Chien-Yuan, et al.
Published: (2011-11-01)

A Systematic Review of Vancomycin Dosing in Patients with Hematologic Malignancies or Neutropenia
by: He N, et al.
Published: (2020-06-01)

Differences in characteristics between first and breakthrough neutropenic fever after chemotherapy in patients with hematologic disease
by: Eun Young Nam, et al.
Published: (2016-03-01)

Use of cefepime, meropenem, or piperacillin/tazobactam as initial treatment for febrile neutropenia in patients with hematological malignancy — a real-life experience
by: Najmul Karim, et al.
Published: (2022-08-01)

Secondary Infections in Febrile Neutropenia in Hematological Malignancies: More Than Another Febrile Neutropenic Episode
by: Aslıhan Demirel, et al.
Published: (2015-07-01)

Ceftolozane-Tazobatam for febrile neutropenia treatment in hematologic malignancy patients colonized by multi-resistant Enterobacteriaceae: preliminary results from a prospective cohort study
by: Francesco Marchesi, et al.
Published: (2020-08-01)

Development and Validation of a Machine Learning Model for the Prediction of Bloodstream Infections in Patients with Hematological Malignancies and Febrile Neutropenia
by: Antonio Gallardo-Pizarro, et al.
Published: (2024-12-01)

Disseminated fusariosis with cutaneous involvement in hematologic malignancies: report of six cases with high mortality rate
by: Marina Zoéga Hayashida, et al.
Published: (2018-10-01)

Dissecting bloodstream infections in febrile neutropenic patients with hematological malignancies, a decade-long single center retrospective observational study (2009–2019)
by: Halima El Omri, et al.
Published: (2024-01-01)

Evaluation of febrile neutropenic patients hospitalized in a hematology clinic
by: Mücahit Görük, et al.
Published: (2015-12-01)

Hemorrhagic Pneumonia Caused by <i>Stenotrophomonas maltophilia</i> in Patients with Hematologic Malignancies—A Systematic Review and Meta-Analysis
by: Chienhsiu Huang, et al.
Published: (2024-01-01)

Carbamazepine and Hematological Malignancies
by: İrfan Yavaşoğlu, et al.
Published: (2013-12-01)

Interpreting Outcome Data in Hematological Malignancies: A Paradigm for Clinical Studies
by: Jacob M. Rowe
Published: (2013-01-01)

Characteristics, Outcomes, and Clinical Indicators of Bloodstream Infections in Neutropenic Patients with Hematological Malignancies: A 7-Year Retrospective Study
by: Wang S, et al.
Published: (2023-07-01)

NEW INSIGHT ON EPIDEMIOLOGY AND MANAGEMENT OF BACTERIAL BLOODSTREAM INFECTION IN PATIENTS WITH HEMATOLOGICAL MALIGNACIES
by: Sara Lo Menzo, et al.
Published: (2015-07-01)

Improvement Of Molecular Methods For Detection Of Pathogenic Escherichia Coli.
by: Abdullah Al-Haj, Nagi Ahmed
Published: (2007)

Current microbiological testing approaches and documented infections at febrile neutropenia onset in patients with hematologic malignancies
by: Chumbita Mariana, et al.
Published: (2024-10-01)

Clinical Characteristics and Optimization of Empirical Antimicrobial Therapy for Febrile Neutropenia in Patients With Hematologic Malignancies
by: Cui Y, et al.
Published: (2025-02-01)

Editorial: Case reports in hematological malignancies: 2022
by: Ahmad Antar, et al.
Published: (2023-08-01)

Atypical Enteropathogenic Escherichia coli: Typical Pathogens?
by: James P. Nataro
Published: (2006-04-01)

Use of inflammatory molecules to predict the occurrence of fever in onco-hematological patients with neutropenia
by: A.F. Tiburcio Ribeiro, et al.
Published: (2013-02-01)

Risk Factors and Outcomes in Critically Ill Patients with Hematological Malignancies Complicated by Hospital-Acquired Infections
by: Adina Yerzhan, et al.
Published: (2023-01-01)

Secondary Infections in Cancer Patients with Febrile Neutropenia
by: Alpay Azap, et al.
Published: (2012-08-01)

Utilidad de la procalcitonina en pacientes adultos con neoplasias hematológicas y neutropenia febril posquimioterapia: Estado del arte Usefulness of procalcitonin in the management of adult patients with hematological malignancies with fever and chemotherapy-induced neutropenia: State of the art
by: Diego Andrés Bonilla, et al.
Published: (2012-12-01)

Echinocandins versus Amphotericin B Against Candida tropicalis Fungemia in Adult Hematological Patients with Neutropenia: A Multicenter Retrospective Cohort Study
by: You L, et al.
Published: (2020-07-01)

Assessment of Long-Term Hematologic Effects in Differentiated Thyroid Cancer Patients Treated with Radioactive Iodine
by: Bircan Sönmez, et al.
Published: (2021-12-01)

Infections in children and adolescents with hematological malignancies
by: Andishe Attarbaschi, et al.
Published: (2023-12-01)

Interactions of pathogenic Escherichia coli with CEACAMs
by: Alaullah Sheikh, et al.
Published: (2023-02-01)

The Phenotype and Functional Activity of Mesenchymal Stromal Cells in Pediatric Patients with Non-Malignant Hematological Diseases
by: Zyrafete Kuҫi, et al.
Published: (2020-02-01)

Genetic makeup and associated virulence posed by the enteropathogenic Escherichia coli and the Enterotoxigenic Escherichia coli pathotypes
by: Syeda Muntaka Maniha, et al.
Published: (2020-01-01)

Inonotosis in Patient with Hematologic Malignancy
by: Ana Fernández-Cruz, et al.
Published: (2018-01-01)

Principales características y diagnóstico de los grupos patógenos de Escherichia coli Diagnosis and main characteristics of Escherichia coli pathogenic groups
by: Guadalupe Rodríguez-Angeles
Published: (2002-09-01)

Characteristic analysis of human parvovirus B19 infection in patients with hematological disease
by: Wei WEI, et al.
Published: (2025-02-01)

Transcription factor genetics and biology in predisposition to bone marrow failure and hematological malignancy
by: Jiarna R. Zerella, et al.
Published: (2023-06-01)

Outcomes of Patients with Hematological Malignancies Admitted to the Intensive Care Unit at a Tertiary Care Center in Saudi Arabia
by: Ghazi Saud Alotaibi, et al.
Published: (2025-01-01)

Breast involvement of hematological malignancies: imaging and clinical findings
by: Gamze Durhan, et al.
Published: (2021-07-01)